Consensus statement on immune modulation in multiple sclerosis and related disorders during the covid-19 pandemic: Expert group on behalf of the indian academy of neurology

Consensus statement on immune modulation in multiple sclerosis and related disorders during the covid-19 pandemic: Expert group on behalf of the indian academy of neurology

Knowledge related to SARS-CoV-2 or 2019 novel coronavirus (2019-nCoV) is still emerging and rapidly evolving. We know little about the effects of this novel coronavirus on various body systems and its behaviour among patients with underlying neurological conditions, especially those on immunomodulat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of the Indian Academy of Neurology 2020-04, Vol.23 (7), p.5-14
Hauptverfasser: Rohit, Bhatia, Padma Srivastava, M, Khurana, Dheeraj, Pandit, Lekha, Mathew, Thomas, Gupta, Salil, Netravathi, M, Nair, Sruthi, Singh, Gagandeep, Singhal, Bhim
Format: Artikel
Sprache:eng
Schlagworte:
B cells
China
Coronaviruses
COVID-19
Dimethyl fumarate
Epidemics
Fingolimod
Health aspects
India
Multiple sclerosis
Teriflunomide
View Point
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Knowledge related to SARS-CoV-2 or 2019 novel coronavirus (2019-nCoV) is still emerging and rapidly evolving. We know little about the effects of this novel coronavirus on various body systems and its behaviour among patients with underlying neurological conditions, especially those on immunomodulatory medications. The aim of the present consensus expert opinion document is to appraise the potential concerns when managing our patients with underlying CNS autoimmune demyelinating disorders during the current COVID-19 pandemic.
ISSN:0972-2327
1998-3549
DOI:10.4103/0972-2327.282442